ALNYLAM PHARMACEUTICALS, INC.·4

Apr 10, 4:29 PM ET

Franchini Indrani Lall 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Apr 10, 2023

Insider Transaction Report

Form 4
Period: 2023-04-06
Franchini Indrani Lall
EVP, CLO & Secretary
Transactions
  • Sale

    Common Stock

    2023-04-06$210.00/sh3,500$735,0000 total
Footnotes (1)
  • [F1]All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT